Meshka Pharma Llp - Due diligence report

A 360° intelligence report on Meshka Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress sign…

2018-04-26 Mumbai, Maharashtra Active
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Meshka Pharma Llp — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Meshka Pharma Llp is assessed as Low Risk with a Trust Score of 77/100. Meshka Pharma Llp is an active limited liability partnership incorporated in 2018, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 15 Oct 2026 from the latest processed filings. Meshka Pharma Llp snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 70/100 Moderate
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MYTHILI SRINIVASAN 01234567 Director 01/04/2018 6 yrs Approved
AYUSH SRINIVASAN 01234567 Director 01/04/2018 6 yrs Approved
SRINIVASAN SUBRAMANIAM 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +38% over 2 year(s).
Operating for 8 years.
Distress signals & risk flags
Revenue declined year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
27 Jul 2018
Director ceased
RAMACHANDRAN VENKATRAMA KUTTUCHERI
26 Apr 2018
Incorporated
Registered with Roc Mumbai
Director appointed
MYTHILI SRINIVASAN (Designated Partner)
Director appointed
AYUSH SRINIVASAN (Designated Partner)
Director appointed
SRINIVASAN SUBRAMANIAM (Designated Partner)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 2 financial year(s).
Net profit margin moved from 2.1x to 24%.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Jagruk Agencies Private Limited U51900MH1999PTC120239 Mumbai, Maharashtra
HUMZZI EV MOTORS LLP AAX-7533 Mumbai, Maharashtra
Maganlal Developers Private Limited U45400MH2011PTC221052 Mumbai, Maharashtra
Sattvam Logistics Private Limited U74999MH2012PTC229713 Mumbai, Maharashtra
Terraform Realstate Limited L27200MH1985PLC035841 Mumbai, Maharashtra
Moraj Realty Private Limited U99999MH1993PTC074007 Mumbai, Maharashtra
Maroon Dot Global Private Limited U15540MH2021PTC374116 Mumbai, Maharashtra
OCC OFFSHORE PROJECTS LLP AAP-5060 Mumbai, Maharashtra
Nhava Sheva Distribution Terminal Private Limited U63023MH2022PTC392812 Mumbai, Maharashtra
Genisis Kreatif Idea Private Limited U73100MH2024PTC424034 Mumbai, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Meshka Pharma Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Meshka Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Meshka Pharma Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Meshka Pharma Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Meshka Pharma Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Meshka Pharma Llp an active company?

Meshka Pharma Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Meshka Pharma Llp financially healthy?

Meshka Pharma Llp has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.

Should I do business with Meshka Pharma Llp?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Meshka Pharma Llp?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Meshka Pharma Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Meshka Pharma Llp up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Meshka Pharma Llp?

Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.